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Summary
In the period from 6 to 21 September, Croatia reported the first clinical cases of hu-
man West Nile virus (WNV) neuroinvasive infection in three counties (Brod-Posavina, Osi-
jek-Baranja and Vukovar-Srijem County). The first case was most probably imported from 
Serbia where the patient resided during the incubation period, while the others represent 
autochthonous cases. Five patients presented with meningoencephalitis and two with me-
ningoencephalitis followed by acute flaccid paralysis. In all samples WNV IgG and/or IgM 
antibodies were detected using enzyme-linked immunosorbent assay (ELISA) and confirmed 
by plaque-reduction neutralization (PRNT) and micro-neutralization test (MNT). Following 
the outbreak, a total of 178 serum samples were collected from healthy inhabitants of Osi-
jek-Baranja County where the incidence of cases were highest. WNV IgG antibodies were 
detected by ELISA in 4 (2.2%) participants indicating the increased WNV circulation in this 
area in comparison with season 2011 resulting in the first reported clinical cases.
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INTRODUCTION
West Nile virus (WNV) is a small, enveloped virus that belongs to the genus 
Flavivirus of the family Flaviviridae [1]. The virus is maintained in an enzootic cycle 
between Culex mosquitoes and birds, whereas humans and horses are considered 
dead-end hosts due to low-level and transient viremia [2]. However, humans may 
occasionally transmit or acquire virus in utero, through breast milk, via blood tran-
sfusion or organ transplantation, or through occupational exposure [3]. Most hu-
man infections (~80%) are asymptomatic. Approximately 20% of infected persons 
develop a non-specific febrile illness (“WNV fever”). A small number of symptoma-
tic cases (<1%) progresses to the neuroinvasive form of infection characterized by 
meningitis, encephalitis and acute flaccid paralysis [4]. The epidemiology of WNV 
is continuously changing and currently the virus has a wide geographic distribu-
tion. After the first isolation of WNV in Uganda in 1937, few outbreaks in humans 
or horses were recorded until the beginning of 1990s [5]. A series of outbreaks in 
the 1990s (Algeria 1994, Morocco 1996, Romania 1996, Tunisia 1997, Italy 1998, Isra-
el 1998, France 2000, and Russia 1999) were associated with severe complications, 
including neuroinvasive disease [6-11]. In 1999, WNV was detected for the first time 
in the Western Hemisphere during the outbreak in New York [12]. In the past few 
years, in European countries, WNV neuroinvasive disease was notified every year: 
Italy (2008-2012), Hungary (2008-2012), Romania (2010-2012) and Greece (2010-2012). 
In July 2012, the first outbreak of WNV disease has occurred in Serbia with 44 labo-
ratory diagnosed cases and six deaths [13].
We are presenting the first human cases of WNV infection in Croatia, August-
September, 2012 and the results of seroepidemiological study performed after the 
transmission season 2012 in Osijek-Baranja County, a region with the highest inci-
dence of WNV neuroinvasive infection during 2012.
MATERIALS AND METHODS
During September-November 2012, a total of 54 serum samples and 15 cerebros-
pinal fluid (CSF) samples from patients with clinical symptoms of WNV infection 
(neuroinvasive disease and WNV fever) were tested at the National Reference Labo-
ratory for Arboviruses, Croatian National Institute of Public Health (CNIPH) for the 
presence of WNV IgM and IgG antibodies using commercial ELISA (Euroimmun, 
Lübeck, Germany). Samples were obtained from hospitalized and non-hospitali-
zed patients with clinical diagnosis of meningoencephalitis (27/50.0%), encephali-
tis (12/22.2%), non-specific febrile disease (13/24.1%) and febrile disease with rash 
(2/3.7%). IgM/IgG reactive samples were further tested for IgG avidity (Euroimmun, 
Lübeck, Germany) to confirm acute/recent WNV infection. The interpretation of 
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AI results was determined as follows: AI <40% = low avidity antibodies indicating 
acute/recent WNV infection; AI 40-60% = moderate avidity; AI >60% = high avidity 
antibodies indicating past WNV infection. Any IgM or IgG positive samples were 
evaluated at the OIE Reference Laboratory for West Nile Disease, Istituto G. Capo-
rale, Teramo, Italy by plaque-reduction neutralization (PRNT) and micro-neutrali-
zation test (MNT) for result confirmation. Nine (5 CSF and 4 serum) samples were 
tested for WNV RNA using real-time pan-flavivirus RT-PCR and qRT-PCR assays 
for detection of WNV lineage 1 and 2 [14,15].
Following the outbreak of WNV infection, from September 2012 to February 
2013, a total of 178 serum samples were collected from healthy inhabitants of Osi-
jek-Baranja County aged 7-86 years where the incidence of neuroinvasive cases was 
highest to evaluate the seroprevalence of WNV. 
RESULTS
Human cases of WNV neuroinvasive infection
Between 6 and 21 September 2012, 7 human cases of WNV neuroinvasive infec-
tion have been diagnosed in three eastern Croatian counties (Brod-Posavina, Osijek-
Baranja and Vukovar-Srijem County), four of which were reported in Osijek-Baranja 
County (Figure 1). Patient’s demographic and clinical characteristics are presented in 
the Table 1. The first case resided in northern Serbian province of Vojvodina during 
the incubation period, while the other represents autochthonous WNV cases. 
Laboratory results
WNV IgM antibodies were detected in all patients. In six patients, IgG antibo-
dies of low avidity were found indicating acute WNV infection. Using PRNT and 
MNT, WNV neutralizing antibodies were confirmed in all samples (Table 1). For two 
patients, paired serum samples were available, which showed a four-fold increase of 
WNV-specific antibody titre. None of the tested CSF samples were WNV antibody 
positive. Real-time RT-PCR was negative in all tested samples.
WNV IgG seroprevalence results
Of 178 tested subjects in Osijek-Baranja County, four (2.2%) were reactive for 
WNV IgG antibodies by ELISA (28-200 RU/ml) while one participant (0.6%) showed 
equivocal result (20 RU/ml). Two seropositive subjects were residents of urban 
settings (Osijek region) and two lived in rural area (Semeljci, Strizivojna) (Figure 1).
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Table 1.  Demographic, clinical and laboratory data of 7 patients with West 
               Nile virus neuroinvasive disease in Croatia, August-September, 2012.
Characteristic Results  
Age
   Median 62  years
   Range 48 - 77 years
Sex
   Male 3 (57.1%)
   Female 4 (42.9%)
Area of residence
   Rural 5 (71.4%)  
   Urban 2 (28.6%)
Clinical symptoms
    Meningoencephalitis 5 (71.4%)
    Meningoencephalitis, AFPa 2 (28.6%)
History of hypertension 4 (57.1%)
Outcome
    Recovered 5 (71.4%)
    Persistent neurologic sequelae  2 (28.6%)
Laboratory results
    WNV ELISA - IgM (Ratio)b 1.7 -  4.1 
    WNV ELISA - IgG  (RU/ml)c 40 - 170  
    WNV IgG avidity 11-38%
    WNV PRNTd (Titre) 5 - 40
    WNV MNTe (Titre) 5 - 80
aAFP = acute flaccid paralysis; bRatio <0.8 neg, 0.8-1.1 equivocal, >1.1 pos;
c<16 neg, 16-22 equivocal, >22 pos; dPRNT = plaque-reduction neutralization
test; eMNT = micro-neutralization test
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DISCUSSION
In Croatia, clinical cases of human WNV infection were not reported so far alt-
hough cases occurred in many European countries (Italy and Hungary 2008-2012, 
Spain 2009, Romania and Greece, 2010-2012) [13]. However, serologic evidence for 
the presence of WNV in Croatia dates back to 1970s. These studies were usually 
based on the detection of hemagglutination inhibiting (HI) antibodies that are gro-
up-specific.  In two studies conducted among residents of the Island Brač in 1970 
and 1974, the prevalence of HI antibodies was 4.9% and 0.28%, respectively [16]. In 
another survey (1980), positive HI results were found in 1.7% Croatian inhabitants: 
1.2% from North-East Croatia, 3.4% from Middle Dalmatia and 0.8% from Southern 
Dalmatia [17]. In a study conducted in 2007 among voluntary blood donors in north-
east Croatia, antibodies against WNV were detected in 0.3% participants by neu-
Figure 1.  Map of Croatia representing human WNV neuroinvasive infection
notified in 2012 and IgG positive participants.
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tralization [18]. A pilot study performed in a group of 306 randomly selected adult 
people aged 30-60 years in 2011 showed similar results. Only one participant (0.3%) 
from eastern Croatia (Osijek-Baranja County) showed positive neutralizing WNV 
antibodies (data from the CNIPH). In addition to humans, antibodies to WNV were 
detected in brown bears in 1993 [19] and horses in 2001-2002 [20]. WNV infection in 
horses was documented in a large study during 2011-2012, the results of which in-
dicate a possible endemic appearance of WNV in Croatia (WNV activity was docu-
mented in at least 9 counties) [21].
The first clinical cases of WNV neuroinvasive disease in Croatia were laboratory 
confirmed in September 2012. A serological survey in sentinel horses demonstrated 
asymptomatic acute WNV infection (detection of IgM antibodies) in 12 animals in 
the same counties where human cases were reported (data from the Faculty of Vete-
rinary Medicine University of Zagreb). The exception is Osijek-Baranja County whe-
re human clinical cases, but not infections in horses were reported. These results 
could be explained by searching the horses for WNV before the increase in vector 
activity. In addition, acutely infected horses were documented in Virovitica-Podra-
vina County in which there were no human cases reported. Since most infected 
people do not show any symptoms or have non-specific febrile disease, it is possible 
that many WNV infections remained unrecognized. 
In areas where cases of WNV infection occurred and in neighboring municipa-
lities, mosquito control measures (adulticidal and larvicidal treatment) were imme-
diately implemented.
Results of seroepidemiological study performed after the transmission season 
2012 in Osijek-Baranja County showed that the seroprevalence rate in healthy in-
habitants increased compared to 2011. The increase in WNV seropositivity in these 
two consecutive years indicates increased viral activity during season 2012. These 
results are in accordance with the first reported clinical cases.
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Sažetak
Infekcija ljudi virusom zapadnog Nila u istočnoj Hrvatskoj, kolovoz – rujan 2012. 
U razdoblju od 6. do 21. rujna 2012. zabilježeni su prvi humani klinički slučajevi ne-
uroinvazivne infekcije virusom zapadnog Nila (VZN) u tri hrvatske županije (Brodsko-po-
savska, Osječko-baranjska i Vukovarsko-srijemska). U prvom se slučaju vjerojatno radilo 
o infekciji podrijetlom iz Srbije, gdje je bolesnik boravio tijekom inkubacijskog perioda, 
a u ostalih bolesnika o autohtonoj infekciji VZN-om. Pet je bolesnika imalo kliničku sliku 
meningoencefalitisa, dok je u dva bolesnika nakon početnih simptoma meningoencefalitisa 
nastupila akutna mlohava kljenut. U svih su dokazana VZN IgG i/ili IgM protutijela pomoću 
imunoenzimnog testa (ELISA) te su potvrđena neutralizacijskim testom redukcije plakova 
(PRNT) i mikroneutralizacijskim testom (MNT). Po završetku sezone sakupljeno je ukupno 
178 uzoraka seruma zdravih osoba s područja Osječko-baranjske županije, gdje je tijekom 
epidemije zabilježen najveći broj slučajeva. Pomoću ELISA testa VZN IgG protutijela doka-
zana su u 4 (2,2%) ispitanika. Ti rezultati ukazuju na povećanu cirkulaciju VZN-a na tom 
području u usporedbi sa sezonom 2011. godine, što je rezultiralo prvim humanim kliničkim 
slučajevima.
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